TET2 and chronic myelomonocytic leukemia: It was also shown in different models that Tet2 loss led to the development of features of human CMML, which was characterized by myeloproliferation and splenomegaly (Li et al., 2011; Moran-Crusio et al., 2011; Quivoron et al., 2011).